GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Diamond Biofund Inc (TPE:6901) » Definitions » Other Income (Expense)

Diamond Biofund (TPE:6901) Other Income (Expense) : NT$-2,226.94 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Diamond Biofund Other Income (Expense)?

Diamond Biofund's other income expense for the Diamond Biofund's pretax income for the three months ended in Dec. 2024 was NT$-607.70 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2,226.94 Mil.


Diamond Biofund Other Income (Expense) Historical Data

The historical data trend for Diamond Biofund's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamond Biofund Other Income (Expense) Chart

Diamond Biofund Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Income (Expense)
Get a 7-Day Free Trial 6,518.04 3,063.47 1,018.09 -2,437.02 -2,226.94

Diamond Biofund Quarterly Data
Dec19 Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 215.00 -773.04 -90.26 -755.93 -607.70

Diamond Biofund Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-2,226.94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diamond Biofund  (TPE:6901) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Diamond Biofund Business Description

Traded in Other Exchanges
N/A
Address
No. 236, Section 4, Xinyi Road,, 11th Floor, Daan District, Taipei City, TWN, 106047
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting global and internationally competitive investment targets, including new drug research and development, high-end medical equipment, innovative medical service technology, medical access, agricultural biotechnology.

Diamond Biofund Headlines

No Headlines